This unique report from VPGMarketResearch provides France sales and market share estimates for major suppliers of clinical chemistry and immunodiagnostic products.
The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
- Agilent Technologies
- Bayer Healthcare
- Beckman Coulter/Danaher
- Biomedical Diagnostics
- Eiken Chemical
- Instrumentation Laboratory
- Kyowa Medex
- Ortho-Clinical Diagnostics
- Quest Diagnostics
- Thermo Fisher
List of Tables
France Sales and Market Shares of Major Suppliers of Clinical Chemistry Diagnostic Products
France Sales and Market Shares of Major Suppliers of Immunodiagnostic Products
Contains 73 pages and 2 tables
SIMILAR MARKET STUDIES
Notes: Production, means the output of UV25 Revenue, means the sales value of UV25 This report studies UV25 in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Master Bond Inc. ...
August 2016 | $2900 | View Details >>
The Database of Medical Device Distributors in Germany offers the most up-to-date perspective on medical device distributors in Germany. The database includes details for nearly 600 medical device distributors in Germany which makes the database an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people ...
January 2013 | $826 | View Details >>
Notes: Sales, means the sales volume of Blood Clotting Factor VIII Revenue, means the sales value of Blood Clotting Factor VIII This report studies sales (consumption) of Blood Clotting Factor VIII in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with ...
August 2016 | $4000 | View Details >>
Summary Enopace Biomedical Ltd. (Enopace) is a medical device company. The company develops devices to treat heart failure patients. Its technology consists of a minimally invasive, implantable neurostimulation device that increases cardiac efficiency by reducing left ventricular workload. The company develops neuromodulation system to treat patients with congestive heart failure. Enopace ...
April 2014 | $250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research